Now accepting a limited number of new Valerian patients each quarter · River Oaks, Houston
Reserve Your Assessment
A prescription manages it.
It does not explain it.
Stem cell signalling for vascular and neural tissue, with hormonal status read in the same panel, because in a substantial number of men the hormones are the actual finding and nobody has looked.
Two different problems
get the same pill.
Reduced desire and reduced function are not the same finding, and they do not usually share a cause. Desire is largely hormonal and neurological. Function is largely vascular. Most men are handed the same prescription regardless of which one brought them in, and a good number of them are being treated for the wrong thing.
That distinction matters clinically. Published two-year data on testosterone replacement in men with hypogonadism and low libido reported improvement in sexual activity, hypogonadal symptoms, and desire, but not in erectile function specifically. Which tells you plainly that if the issue is purely vascular, hormones alone will not resolve it, and if the issue is desire, a vasodilator will not either.
The program here begins by establishing which one you are actually dealing with, and frequently finds both. That answer comes from a panel, not from a questionnaire, and where hormones are the driver, correcting them is the intervention rather than an add-on to it.
Decreased Libido
Reduced desire independent of function. Frequently the first symptom to appear and the one most often dismissed as stress or age.
Hormonal Imbalance
Low or low-normal testosterone, elevated estradiol conversion, high SHBG limiting free testosterone, or thyroid dysfunction, any of which can present exactly like this.
Vascular & Tissue Health
Blood flow and tissue quality, where the mechanism is circulatory rather than hormonal. This is where the cellular side of the program applies.
Diminishing Response to Medication
For men where a PDE-5 inhibitor is working less well than it did. That is usually a signal about the underlying tissue and hormonal environment rather than about the dose.
Establish the mechanism
before treating anything.
Comprehensive Panel
Total and free testosterone, estradiol, SHBG, LH, FSH, prolactin, full thyroid, and cardiovascular and metabolic markers. Vascular health is systemic, and what shows up here is frequently the earliest visible sign of it.
Correct the Hormonal Picture
Where the panel points at testosterone, estradiol conversion, SHBG, or thyroid, that is addressed first. For a meaningful share of men this alone changes the picture, and no further intervention is needed.
Cellular Delivery Where Indicated
Where the mechanism is vascular and tissue-level, stem cell preparations are used to signal repair in that tissue. Delivered in a private setting, outpatient, with the same sourcing standard applied everywhere here.
Follow-Up & Refinement
Panels at six to eight weeks with hematocrit, estradiol, and PSA tracked where TRT is part of the program. Most protocols require adjustment in the first cycle. That is the design working.
Cellular preparations are investigational and are not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease or condition. Published data on testosterone replacement and sexual function in hypogonadal men is available at PubMed (PMID 37589949). Candidacy is determined by the physician. Individual results vary.
This is a category
built on not asking questions.
Most of what is sold here is sold quickly, online, without a panel and without anyone establishing what is actually happening. The convenience is real. So is the cost of skipping the diagnosis.
A Panel, Not a Questionnaire
Telehealth services prescribe from a form. That works until it does not, and it never establishes whether the finding was hormonal, vascular, or both. Here the panel comes first, every time.
What It May Be Telling You
Erectile function depends on vascular health, and vascular health is systemic. A change here can be the earliest visible indicator of something worth investigating more broadly. That gets taken seriously rather than treated symptomatically.
Sourcing You Can Verify
Cellular preparations come from AATB-accredited, FDA-registered tissue establishments under current Good Tissue Practices, with lot-level documentation. The same standard as every other program here.
Complete Discretion
Private arrival, private suite, by appointment only. No waiting room, and nothing about the visit that identifies why you are here. For most men in this program that is not a preference.
What Valerian patients ask
before they commit.
You may not need to. A PDE-5 inhibitor working well is a reasonable place to be, and nobody here will tell you otherwise. What it does not do is tell you why you needed it, and that answer occasionally matters, because erectile function depends on vascular health, and vascular health is systemic. If the medication is working less well than it once did, that is usually a signal about the underlying tissue and hormonal environment rather than about the dose. The panel establishes which.
That is exactly the question the assessment answers, and it is worth understanding why it matters. Desire is largely hormonal and neurological. Erectile function is largely vascular. Published two-year data on testosterone replacement in men with hypogonadism and low libido found improvement in sexual activity, hypogonadal symptoms, and desire, but not in erectile function specifically. So treating one when the finding is the other produces disappointment. In practice both are frequently present, and the panel tells us the proportions. The data is at PubMed.
Because it is frequently the finding nobody looked for. Low or low-normal testosterone, elevated estradiol conversion, high SHBG limiting free testosterone, and thyroid dysfunction can all present the way you are describing. A telehealth service prescribing from a questionnaire will never surface any of them. Where hormones are the driver, correcting them is the intervention rather than something added alongside it. See HRT & TRT for how that program runs.
Stem cell preparations signal repair in vascular and neural tissue rather than replacing anything or overriding function the way a medication does. Where the panel indicates the mechanism is tissue-level rather than hormonal, that is where it applies. These are investigational applications, not FDA-approved for any condition, and candidacy is a physician determination made from your results. Sourcing, culture method, and lot verification are covered on the Stem Cells page if you want to know what is actually in the vial.
Entirely. Private arrival, a private suite, by appointment only, no shared waiting area, and nothing in the visit that identifies why you are here. A private arrival lane is available for Valerian patients who require additional discretion. Your clinical information is never shared without explicit consent. For most men in this program that is a requirement rather than a preference, and the practice was built with that assumption.
No. Valere operates as a private-pay practice. That is what allows the panel to be as comprehensive as it is and the physician time to be what it is. An insurance-driven model would not support a full hormonal and vascular workup for someone whose total testosterone reads inside the reference range. Payment plans and membership options are available.
Find out what it is
before you manage it.
Your assessment establishes whether this is hormonal, vascular, or both. Private, unhurried, and physician-guided from the first appointment.
Reserve Your AssessmentPrivate · By appointment only · River Oaks, Houston